These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 20095795)
41. Evaluation and treatment of GERD and upper GI complaints in athletes. Leggit JC Curr Sports Med Rep; 2011; 10(2):109-14. PubMed ID: 21623293 [TBL] [Abstract][Full Text] [Related]
42. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease. Ruigómez A; Hungin AP; Lundborg P; Johansson S; Wallander MA; García Rodríguez LA Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):232-7. PubMed ID: 21258240 [TBL] [Abstract][Full Text] [Related]
43. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Dickman R; Schiff E; Holland A; Wright C; Sarela SR; Han B; Fass R Aliment Pharmacol Ther; 2007 Nov; 26(10):1333-44. PubMed ID: 17875198 [TBL] [Abstract][Full Text] [Related]
44. Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey. Chey WD; Inadomi JM; Booher AM; Sharma VK; Fendrick AM; Howden CW Am J Gastroenterol; 2005 Jun; 100(6):1237-42. PubMed ID: 15929751 [TBL] [Abstract][Full Text] [Related]
46. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both? Tack J; Koek G; Demedts I; Sifrim D; Janssens J Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713 [TBL] [Abstract][Full Text] [Related]
47. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Zerbib F; Duriez A; Roman S; Capdepont M; Mion F Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358 [TBL] [Abstract][Full Text] [Related]
48. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679 [TBL] [Abstract][Full Text] [Related]
49. New algorithm for the treatment of gastro-oesophageal reflux disease. Tytgat GN; McColl K; Tack J; Holtmann G; Hunt RH; Malfertheiner P; Hungin AP; Batchelor HK Aliment Pharmacol Ther; 2008 Feb; 27(3):249-56. PubMed ID: 17973975 [TBL] [Abstract][Full Text] [Related]
50. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Boardman HF; Heeley G Int J Clin Pharm; 2015 Oct; 37(5):709-16. PubMed ID: 26100836 [TBL] [Abstract][Full Text] [Related]
51. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease. Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439 [TBL] [Abstract][Full Text] [Related]